Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Prospective, Multi-Center Clinical Study of the BD® WavelinQ™ EndoAVF System for the Creation of Arteriovenous (AV) Fistula in Patients Requiring Dialysis

NCT04634916 is registered in ClinicalTrials.gov with C. R. Bard as lead sponsor.

NCT NCT04634916
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04634916 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Prospective, Multi-Center Clinical Study of the BD® WavelinQ™ EndoAVF System for the Creation of Arteriovenous (AV) Fistula in Patients Requiring Dialysis
Lead sponsor
C. R. Bard
Phase
Not applicable
Overall status
Recruiting
Start date
March 26, 2021
Completion date
September 30, 2027
Enrollment
220 (estimated)
Sites
17

Conditions

As the registry lists them; a condition with its own page is linked.

arteriovenous fistula, end-stage renal disease, kidney disease, end-stage